Cargando…

Diagnostic performance of gliomas grading and IDH status decoding A comparison between 3D amide proton transfer APT and four diffusion‐weighted MRI models

BACKGROUND: The focus of neuro‐oncology research has changed from histopathologic grading to molecular characteristics, and medical imaging routinely follows this change. PURPOSE: To compare the diagnostic performance of amide proton transfer (APT) and four diffusion models in gliomas grading and is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Hu, Liu, Jun, Hu, JunJiao, Zhang, HuiTing, Zhao, Wei, Gao, Min, Zhang, Yi, Yang, Guang, Cui, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9790544/ https://www.ncbi.nlm.nih.gov/pubmed/35488516 http://dx.doi.org/10.1002/jmri.28211

Ejemplares similares

NI-09 Amide Proton Transfer (APT) image is useful for diagnostic imaging of glioma
por: Shirota, Masami, et al.
Publicado: (2020)

APT weighted imaging in diffuse gliomas
por: Nichelli, Lucia, et al.
Publicado: (2023)

Chemical Shift-Encoded Sequence (IDEAL-IQ) and Amide Proton Transfer (APT) MRI for Prediction of Histopathological Factors of Rectal Cancer
por: Peng, Yang, et al.
Publicado: (2023)

Vessel Size Imaging is Associated with IDH Mutation and Patient Survival in Diffuse Lower-Grade Glioma
por: Kang, Houyi, et al.
Publicado: (2020)

Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma
por: Deng, Xiangyang, et al.
Publicado: (2019)

Characterization of Lung Cancer by Amide Proton Transfer (APT) Imaging: An In-Vivo Study in an Orthotopic Mouse Model
por: Togao, Osamu, et al.
Publicado: (2013)

Analysis of safety and efficacy of proton radiotherapy for IDH-mutated glioma WHO grade 2 and 3
por: Eichkorn, Tanja, et al.
Publicado: (2023)

Noninvasive amide proton transfer magnetic resonance imaging in evaluating the grading and cellularity of gliomas
por: Bai, Yan, et al.
Publicado: (2016)

Comparing different analysis methods for quantifying the MRI amide proton transfer (APT) effect in hyperacute stroke patients
por: Tee, Y. K., et al.
Publicado: (2014)

Amide Proton Transfer (APT) imaging in tumor with a machine learning approach using partially synthetic data
por: Viswanathan, Malvika, et al.
Publicado: (2023)

Pharmacoresistant seizures and IDH mutation in low-grade gliomas
por: Correia, Carlos Eduardo, et al.
Publicado: (2021)

Seizures in patients with IDH-mutated lower grade gliomas
por: Carstam, Louise, et al.
Publicado: (2022)

IDH mutation-specific radiomic signature in lower-grade gliomas
por: Liu, Xing, et al.
Publicado: (2019)

Grading of Glioma: combined diagnostic value of amide proton transfer weighted, arterial spin labeling and diffusion weighted magnetic resonance imaging
por: Kang, Xiao-wei, et al.
Publicado: (2020)

Correlation between amide proton transfer-related signal intensity and diffusion and perfusion magnetic resonance imaging parameters in high-grade glioma
por: Nakajo, Masanori, et al.
Publicado: (2021)

IDH mutations but not TERTp mutations are associated with seizures in lower-grade gliomas
por: Duan, Wen-chao, et al.
Publicado: (2018)

PREOPERATIVE DETERMINATION OF IDH STATUS AND GRADE IN GLIOMAS USING MRS
por: Nguyen, Thanh Binh
Publicado: (2023)

Differentiation between high-grade gliomas and solitary brain metastases: a comparison of five diffusion-weighted MRI models
por: Mao, Jiaji, et al.
Publicado: (2020)

Transcriptional Characteristics of IDH-Wild Type Glioma Subgroups Highlight the Biological Processes Underlying Heterogeneity of IDH-Wild Type WHO Grade IV Gliomas
por: Chang, Yu-Zhou, et al.
Publicado: (2020)

Diffusion tensor image features predict IDH genotype in newly diagnosed WHO grade II/III gliomas
por: Eichinger, Paul, et al.
Publicado: (2017)

Amide Proton Transfer Imaging vs Diffusion Kurtosis Imaging for Predicting Histological Grade of Hepatocellular Carcinoma
por: Wu, Baolin, et al.
Publicado: (2020)

The Value of Enhanced MR Radiomics in Estimating the IDH1 Genotype in High-Grade Gliomas
por: Niu, Lei, et al.
Publicado: (2020)

Changes in clinical management of diffuse IDH-mutated lower-grade gliomas: patterns of care in a 15-year period
por: Svenjeby, Caroline, et al.
Publicado: (2022)

Reproducibility of 3 T APT‐CEST in Healthy Volunteers and Patients With Brain Glioma
por: Wamelink, Ivar J.H.G., et al.
Publicado: (2022)

TERT promoter mutations contribute to IDH mutations in predicting differential responses to adjuvant therapies in WHO grade II and III diffuse gliomas
por: Zhang, Zhen-Yu, et al.
Publicado: (2015)

Amide Proton Transfer Imaging in Predicting Isocitrate Dehydrogenase 1 Mutation Status of Grade II/III Gliomas Based on Support Vector Machine
por: Han, Yu, et al.
Publicado: (2020)

Grading of IDH-mutant astrocytoma using diffusion, susceptibility and perfusion-weighted imaging
por: Yang, Xiefeng, et al.
Publicado: (2022)

Pre-surgical connectome features predict IDH status in diffuse gliomas
por: Kesler, Shelli R., et al.
Publicado: (2019)

Computational Analysis of IDH1, IDH2, and TP53 Mutations in Low-Grade Gliomas Including Oligodendrogliomas and Astrocytomas
por: Bendahou, Mohammed Amine, et al.
Publicado: (2020)

Operation of the Low-Energy Demonstration Accelerator: The Proton Injector for APT
por: Schneider, J D
Publicado: (1999)

The comparison of clinical and biological characteristics between IDH1 and IDH2 mutations in gliomas
por: Wang, Hao-Yuan, et al.
Publicado: (2016)

Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype: case series of a new entity
por: Bender, Katja, et al.
Publicado: (2023)

Amide Proton Transfer Imaging of Diffuse Gliomas: Effect of Saturation Pulse Length in Parallel Transmission-Based Technique
por: Togao, Osamu, et al.
Publicado: (2016)

The Diagnostic Value of Apparent Diffusion Coefficient and Proton Magnetic Resonance Spectroscopy in the Grading of Pediatric Gliomas
por: Yao, Rong, et al.
Publicado: (2021)

IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas
por: Zhang, Lei, et al.
Publicado: (2018)

Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study
por: Zhang, Jun, et al.
Publicado: (2021)

Evaluation of gliomas peritumoral diffusion and prediction of IDH1 mutation by IVIM-DWI
por: Gu, Taifu, et al.
Publicado: (2021)

Tissue metabolites in diffuse glioma and their modulations by IDH1 mutation, histology, and treatment
por: Trautwein, Christoph, et al.
Publicado: (2022)

NGMA-1. Quantification of IDH mutant alleles predicts outcome in diffuse gliomas
por: Voisin, Mathew, et al.
Publicado: (2021)

Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma()()
por: Sun, Chao, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_khsa7ml1v6hodmjkbia6b8of90